FASTEST

The following are some additional information with regards to FASTEST:

• The purpose of this study is to see if getting Recombinant Factor VIIa (rFVIIa) within 2 hours (120 minutes) of the brain bleed can improve how well patients become after 6 months.

• Spontanous ICH

• rFVIIa vs. placebo

• To Randomize/Consent and perform other tasks - WebDCU™ (musc.edu) 

Inclusion/Exclusion Criteria:

Study Drug Compounding Directions:
** Scan barcode for video directions! **